Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Age
18 years - 99 years
Gender
All
Location
1
Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Brief description of study

An Open-Label, Multicenter, First-in-Human, Dose-Escalation Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Metastatic Solid Tumors,cancer,Sarcomas
  • Age: 18 years - 99 years
  • Gender: All

Male and Female Age 18 or older Metastatic Solid Tumors and/or Sarcomas

Updated on 04 Aug 2024. Study ID: 849673
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research